Some breast cancer treatments may limit effectiveness of weight loss medications

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainBreast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presen

Updated on: February 03,2024

Some breast cancer treatments may limit effectiveness of weight loss medications

by The Endocrine SocietyCredit: Unsplash/CC0 Public DomainBreast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presen

Updated on:February 03,2024

Researchers find an epigenetic key that unlocks common deadly cancers

by Katherine Fenz,Rockefeller UniversityLesions (in green) akin to basal cell carcinoma that were induced by SOX9 in the epidermis. Abnormal differentiation is shown in red, and blue marks cell

Updated on: February 18,2024

Researchers find an epigenetic key that unlocks common deadly cancers

by Katherine Fenz,Rockefeller UniversityLesions (in green) akin to basal cell carcinoma that were induced by SOX9 in the epidermis. Abnormal differentiation is shown in red, and blue marks cell

Updated on:February 18,2024

Clinicians supporting cancer patients with taste loss need educational materials and training, finds survey

by University of Massachusetts AmherstParticipants describe important criteria to consider upon developing educational materials to facilitate learning about taste alterations. Credit:Suppo

Updated on: February 01,2024

Clinicians supporting cancer patients with taste loss need educational materials and training, finds survey

by University of Massachusetts AmherstParticipants describe important criteria to consider upon developing educational materials to facilitate learning about taste alterations. Credit:Suppo

Updated on:February 01,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on: January 30,2024

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Updated on:January 30,2024

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center Deputy Director and Associate Dean for Research at the Colorado School of Public Health. Credit: University of Colorado Cancer Ce

Updated on: April 23,2024

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center Deputy Director and Associate Dean for Research at the Colorado School of Public Health. Credit: University of Colorado Cancer Ce

Updated on:April 23,2024

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on: February 18,2024

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on:February 18,2024

Drug combination discovery may extend life expectancy of children with brain cancer

by Newcastle UniversityCredit: Unsplash/CC0 Public DomainNewcastle and Hunter-based researchers have discovered a drug combination that could improve the life expectancy of children with brain ca

Updated on: February 18,2024

Drug combination discovery may extend life expectancy of children with brain cancer

by Newcastle UniversityCredit: Unsplash/CC0 Public DomainNewcastle and Hunter-based researchers have discovered a drug combination that could improve the life expectancy of children with brain ca

Updated on:February 18,2024

Formation of new blood vessels in tumors regulated by p38 protein

by Institute for Research in Biomedicine (IRB Barcelona)Structure of a blood vessel. Credit: Raquel Batlle, IRB BarcelonaA study performed at the Institute for Research in Biomedicine(IRB Barcelo

Updated on: April 07,2024

Formation of new blood vessels in tumors regulated by p38 protein

by Institute for Research in Biomedicine (IRB Barcelona)Structure of a blood vessel. Credit: Raquel Batlle, IRB BarcelonaA study performed at the Institute for Research in Biomedicine(IRB Barcelo

Updated on:April 07,2024

Study: Conventional radiotherapy should remain standard of care for localized vertebral metastases of the spine

by NRG OncologyCredit: Pixabay/CC0 Public DomainResults from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the sp

Updated on: January 22,2024

Study: Conventional radiotherapy should remain standard of care for localized vertebral metastases of the spine

by NRG OncologyCredit: Pixabay/CC0 Public DomainResults from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the sp

Updated on:January 22,2024

Researchers program cancer-fighting cells to resist exhaustion, attack solid tumors in mice

by Stanford University Medical CenterCredit: CC0 Public DomainA new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiven

Updated on: June 24,2024

Researchers program cancer-fighting cells to resist exhaustion, attack solid tumors in mice

by Stanford University Medical CenterCredit: CC0 Public DomainA new approach to programing cancer-fighting immune cells called CAR-T cells can prolong their activity and increase their effectiven

Updated on:June 24,2024

Team uncovers promising lead in genetic approach to treating glioblastoma

by Anna C. Christensen,University of ArizonaBaldassarre Stea, MD, PhD, (center), treats brain tumors with DNA-damaging radiation. Credit: Anna C. ChristensenGlioblastoma, a deadly brain cancer t

Updated on: May 27,2024

Team uncovers promising lead in genetic approach to treating glioblastoma

by Anna C. Christensen,University of ArizonaBaldassarre Stea, MD, PhD, (center), treats brain tumors with DNA-damaging radiation. Credit: Anna C. ChristensenGlioblastoma, a deadly brain cancer t

Updated on:May 27,2024